The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1210/jc.2006-1882
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, DPP-4 inhibitors, type 2 diabetes, endogenous glucose production, glucagon-like peptide-1, insulin secretion, glucagon suppression, postprandial blood glucose, meal tolerance test, islet function, single-dose administration, glucose homeostasis, fasting blood glucose, dipeptidyl peptidase IV
Open Access status: closed
OpenAlex ID: W1970498822
